Wolters Kluwer Survey: Physician Assistant Workforce Steps up Amid Clinician Shortages, Fragmented Care Landscape, and Changing Patient Demands

A new Wolters Kluwer survey highlights AI adoption, key challenges in practice, and educational gaps for the fast-growing PA profession WALTHAM, Mass.–(BUSINESS WIRE)–According to new survey findings from Wolters Kluwer Health, AI is a fixture in clinical practice for physician assistants (PAs) – also referred to as physician associates – with 56% reporting daily use … [Read more…]

New MERGE Research Finds Better Portal Design Is Key to Restoring Trust in Health Insurers

MERGE identifies key opportunities for health insurers to transform member portals and close experience gap CHICAGO–(BUSINESS WIRE)–MERGE, a leading marketing and technology agency, released new research today that found most health insurance portals are falling short of member expectations, creating frustration, inefficiency, and financial strain. The white paper, “The Portal Payoff: A Study of 13 … [Read more…]

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

Encouraged that at Least One Member of STAAR’s Board Recognizes the Flaws of the Sale Process and that the Go-Shop Process was Performative Questions Completeness of Disclosures Given Critical Omission of Inbound Interest from Respected Private Equity Firm that Indicated It Would Pay More than Alcon Notes That STAAR’s Board Did Not Obtain an Updated … [Read more…]

Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman

Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026 Announcement Follows Year of Dual CEO / COO Model and Returns Company to Single Leader Structure TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the Board of Directors’ decision to appoint … [Read more…]

Innate Pharma Releases Its 2026 Financial Calendar

MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May 13, 2026: Publication of revenue and cash position for 1Q2026 May 21, 2026: Annual General Shareholders Meeting September 17, 2026: Publication of half year … [Read more…]

ScoliCare® Seattle Washington Celebrates Grand Opening

New Clinic Brings Advanced Healthcare to Seattle for Individuals with Scoliosis SEATTLE–(BUSINESS WIRE)–People living with scoliosis in Washington State now have access to world-class, non-surgical treatment options with the Grand Opening of ScoliCare Seattle. This new clinic delivers a patient-centered approach to scoliosis management, combining advanced technology with expert clinical care to improve quality of … [Read more…]

Maxim Healthcare Applauds Introduction of the Continuous Skilled Nursing Quality Improvement Act of 2025

The bipartisan legislation introduced by Congressman Rulli (R-OH-6) and Congressmen Stanton (D-AZ-4) and Pappas (D-NH-1) seeks to strengthen Medicaid nursing services WASHINGTON–(BUSINESS WIRE)–Congressman Rulli (R-OH-6) and Congressmen Stanton (D-AZ-4) and Pappas (D-NH-1) announced the introduction of the Continuous Skilled Nursing Quality Improvement Act of 2025, aimed at improving the quality and accessibility of skilled nursing … [Read more…]

Propeller and The Legends for Charity® Dinner Invite Fans to Enter to Win Tickets to Super Bowl LX, Benefiting St. Jude Children’s Research Hospital

MEMPHIS, Tenn.–(BUSINESS WIRE)–Propeller, the digital platform that connects fans to causes through culture, community and experiences, today announced an opportunity to take action to be entered to win two tickets to Super Bowl LX with proceeds benefitting the lifesaving mission of St. Jude Children’s Research Hospital®: Finding cures. Saving children.® The opportunity is offered in … [Read more…]

SABER Applauds Dr. Paula N. Brown for Landmark JAOAC Paper Exposing Misbranded “Kratom Extracts” with Elevated 7-Hydroxymitragynine

New peer-reviewed research provides a clear scientific basis to distinguish authentic kratom from synthetic/adulterated products, advancing consumer safety and evidence-based regulation. CLEVELAND–(BUSINESS WIRE)–The Scientific Association for Botanical Education and Research (SABER) congratulates Steering Committee member Dr. Paula N. Brown and co-authors on the publication of “Elevated 7-Hydroxymitragynine Levels Found in Products Misbranded as Kratom” in … [Read more…]

Ensoma Announces Clearance of U.K. Clinical Trial Authorization Application for EN-374, First In Vivo HSC-Directed Gene Insertion Therapy

MHRA authorization to initiate Phase 1/2 clinical trial at U.K. sites follows first U.S. patient dosing with EN-374 for treatment of X-linked chronic granulomatous disease BOSTON–(BUSINESS WIRE)–Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) … [Read more…]